Inflammation-based prognostic score as a predictor of postoperative gastric cancer recurrence

Anticancer Research

Volumn 32, Issue 10, 2012, Pages 4581-4584

  Mohri, Yasuhiko ^a   Tanaka, Koji ^a   Ohi, Masaki ^a   Toiyama, Yuji ^a   Yasuda, Hiromi ^a   Inoue, Yasuhiro ^a   Uchida, Keiichi ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Prognosis; Systemic inflammatory response

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HYPOALBUMINEMIA; INFLAMMATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; STOMACH CANCER; TUMOR VOLUME;

AGED; C-REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMANS; HYPOALBUMINEMIA; INFLAMMATION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR BURDEN;

EID: 84867792975     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150, 2006. (Pubitemid 46655601)
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global Cancer Statics CA Cancer J Clin 61: 69-90, 2011.
3. Siegel R, Ward D, Brawley O, and Jemal A: Cancer statistics, 2011. CA Cancer J Clin 62: 10-29, 2012.
4. Allgayer H, Heiss MM and Schildberg FW: Prognostic factors in gastric cancer. Br J Surg 84: 1651-1664, 1997. (Pubitemid 27519590)
5. Forrest LM, McMillan DC, McArdle CS and Dunlop DJ: A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 92: 1834-1836, 2005. (Pubitemid 40826128)
6. Crumley AB, McMillan DC, McKeman M, Going JJ, Shearer CJ and Stuart RC: Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer 94: 637-641, 2006. (Pubitemid 43361893)
7. Glen P, Jamieson NB, McMillan DC, Carter R, Imrie CW, and McKay CJ: Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6: 450-453, 2006. (Pubitemid 44624278)
8. Ramsey S, Lamb GW, Aitchison M, Graham J and McMillan DC: Evaluation of an inflammation-based score in patients with metastatic renal cancer. Cancer 109: 205-212, 2007. (Pubitemid 46106235)
9. Toiyama Y, Miki C, Inoue Y, Tanaka K, Mohri Y and Kusunoki M: Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med 2: 95-101, 2011.
10. Elahi MM, McMillan DC, McArdle DC, Angerson WJ and Sattar N: Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer 48: 171-173, 2004. (Pubitemid 39045778)
11. Nozoe T, Iguchi T, Egashira A, Egashira A, Adachi E, Matsukuma A and Ezaki T: Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastic carcinoma. Am J Surg 201: 186-191, 2011.
12. AJCC Cancer Staging Manual, 6th edn. New York: Springer-Verlag, 2002.
13. Rohatgi PR, Yao JC, Hess K, Schnirer I, Rashid A, Mansfield PF, Pisters PW and Ajani JA: Outcome of gastric cancer patients after successful gastrectomy: Infuluence of the type of recurrence and histology on survival. Cancer 107: 2576-2580, 2006. (Pubitemid 44845610)
14. Ikuta S, Miki C, Tanaka K, Konishi N, Mohri Y, Tonouchi H and Kusunoki M: Serum immunosuppressive acidic protein as an interleukin-6 related index of deteriorating condition in gastric cancer patients. Dig Surg 20: 532-538, 2003. (Pubitemid 37329227)
15. Deans DA, Wigmore SJ, Gilmour H, Paterson-Brown S, Ross JA and Fearon KC: Elevated tumour interleukin-1β is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. Br J Cancer 95: 1568-1575, 2006. (Pubitemid 44863361)
16. Ikeguchi M, Hatada T, Yamamoto M, Miyake T, Matsunaga T, Fukumoto Y, Yamada Y, Fukuda K, and Saito H, and Tatebe S: Serum interleukin-6 and -10 levels in patients with gastric cancer. Gastric Cancer 12: 95-100, 2009.
17. Kim DK, Oh SY, Kwon HC, Lee S, Known KA, Kim BG, Kim SG, Kim SH, Jang JS, Kim MC, Kim KH, Han JY and Kim HJ: Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer 9: 155, 2009.
18. DeNardo DG, Johansson M and Coussens LM: Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev 27: 11-18, 2008.